False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...
An academic partnership to improve diversity in clinical trials has drafted its first industry team members. | An academic ...
In a report released today, Michael Yee from Jefferies assigned a Buy rating to Amgen (AMGN – Research Report), with a price target of ...
With a sold-out crowd and a ton of momentum, Rory McIlroy appeared poised to post his first DP World Tour victory on Northern ...
GOLF fans were left in shock this afternoon as Rasmus Hojgaard earned the 2024 Amgen Irish Open title. But it was heartbreak ...
Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The ...
Business Eye on MSN2h
Tourism Northern Ireland Hails Success Of Amgen Irish OpenTourism Northern Ireland has described the recent Amgen Irish Open in Co Down as “incredibly successful”. More than 71,000 ...
Rory McIlroy is on familiar soil. Eleven days after a tie for ninth in the Tour Championship, McIlroy fired a first-round 68 ...
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback